Drug Shortage Report for ERYTHROMYCIN OPHTHALMIC OINTMENT USP
Report ID | 26749 |
Drug Identification Number | 02326663 |
Brand name | ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP |
Common or Proper name | Erythromycin ophthalmic ointment USP |
Company Name | STERI-MED PHARMA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 5MG |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 3.5g |
ATC code | S01AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-02-08 |
Estimated end date | 2018-09-21 |
Actual end date | 2018-09-20 |
Shortage status | Resolved |
Updated date | 2018-09-21 |
Company comments | Pending for analysis |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 242, RUE SAINT-CYRILLE OUEST UPTON, QUEBEC CANADA J0H 2E0 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2017-10-23 | French | Compare |
v2 | 2017-10-23 | English | Compare |
v1 | 2017-10-23 | English | Compare |